-
GTA 6 Release Date Confirmed for November 19; Troubleshooting Pre-load and Launch Errors
-
Peaceful Repeat Vote in Douglas Ward 3 Amid Heightened Security
-
‘They want silence’: how the film NAZA is shaking Israel
-
Belgian Ambassador Marks King’s Day in Athens Amidst Strong Bilateral Trade Ties
-
Dún Laoghaire-Rathdown €335m Budget Faces Mixed Reaction Over Housing and Cost of Living
-
Rediff.com IPO Risks: Gmail Dominance and New Business Ventures
-
BING X: 22,624.66 SNC have disappeared at BingX – how safe are tokens on BingX? Will BingX’s MiCAR licence be suspended?
-
Dubai Police Expand Luxury Patrol Fleet with 525-hp Defender
-
Iran Strikes US Sites in Kuwait Following US Airstrikes on Qeshm Island
-
Wedgewood Weddings Acquires Swan Lake Overlook, Where Alpacas, Deer, and Mountain Views Join the Guest List
-
Olenox October Bitcoin Production Climbs to Three-Month High as Uptime and Hashrate Advance
-
DSS Announces Completion of Impact Biomedical Business Combination with Zoar Limited
-
Newsmax Expands Over-the-Air Reach with HC2 Broadcasting Distribution Agreement for Newsmax2
-
Impala and Philanthropy Southwest Launch Southwest Hub, Mapping Philanthropy Across Eight States
-
HTB Activ(TM) Trial Demonstrates Significant Improvement in Cognitive Abilities
-
Nixxy Announces 1-for-20 Reverse Stock Split
-
IGC Pharma Completes Dosing in Phase 2 CALMA Trial of IGC-AD1 for Agitation in Alzheimer's Dementia
-
The IRS Watchdog Just Published Its FY 2027 Challenges List - Clear Start Tax Explains Why Agency Strain Rarely Slows Down Collection Notices
-
Who Does the Best Deep Plane Facelift in Oklahoma?
-
LHH ICEO Research Led by Harvard Business School Professor Maps Four Paths for Work Beyond the C-Suite
-
cbdMD Applauds Introduction of the Bipartisan Hemp Guardrails Act, Calling It a Win for Consumer Safety, American Jobs and Tax Revenue
-
Bell Rose Capital (OTCID:BELR) Makes Major Move Into Streaming Entertainment With Spark TV Partnership And New Billy Carson Series "The Missing Chapter"
-
Investments & Wealth Institute Expands Advanced Education Offerings for 2027, Announces Next Experience Conference in Nashville
-
Dermata Announces U.S. Trademark Registration for TOME(R)
-
Tocvan Defines Priority Gold Target Areas at Gran Pilar From Project-Wide Soil Sampling and Geologic Mapping; 225 Soils at or Above 100 ppb Gold
-
ESGold Expands Montauban Gold-Silver Property to Approximately 26,787 Hectares Through Strategic Claim Staking
-
NuRAN Wireless Raises First Two Towers in Benin as 4G Rollout Beats Expectations in Cameroon and Ivory Coast
-
Rockhaven Announces Successful Completion of 2026 Klaza Bulk Sample Program
-
Silver Storm to Attend the 121 Mining Investment Conference in London, UK
-
American Resources Corporation Provides Strategic Business and Financial Reporting Update
-
Who Does the Best Deep Plane Facelift in Sarasota?
-
Jumia Reports Third Quarter 2026 Results
-
Ameriwest Advances Its Copper Focused Strategy Through Proposed Sale of Railroad Valley to Pure Energy Minerals
-
1933 Industries Completes LED Lighting Retrofit at Its 68,000 Sq. Ft. Cannabis Cultivation Facility in Las Vegas, Nevada - Ranks #3 in Cannabis Flower Sales
-
AbTherx Licenses Atlas(TM) Platform to Athenova Therapeutics for Next-Generation Targeted Alpha Radiopharmaceutical Discovery
-
DataMeds AI Subsidiary Helomics, Inc. Announces Cancer Target Discovery and Anticancer Peptides Drug Development Partnership With DiaGen AI, Inc.
-
What to Do When Two Households Become One
-
SmartBuyerAI Gives Car Buyers an Itemized Check of Dealer Offers as FTC Steps Up Price Transparency Enforcement
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 18
-
Fulcrum Metals PLC Announces Uranium Readings up to 0.42% U(3)O(8) at Charlot-Neely
-
Coa Wealth Launches AI-Powered Software That Functions as a Private Investment Office for Individual Investors and Families
-
Healthcare AI Shakeout: Health Systems Plan to Cut AI Vendors Nearly in Half by 2028, Black Book Finds
-
Sparta Capital Ltd. Announces Resumption of Trading
-
TrizCom PR Wins Fourth PRSA Dallas Best of Show Award; Founder Jo Trizila Receives Norm Teich Award
-
CORRECTION FROM SOURCE: Nixxy Announces 1-for-20 Reverse Stock Split
-
Olenox Secures Texas Pipeline Operating Permit, Clearing Path for Initial 4 MW Power Deployment
-
Wyyerd Fiber Brings Arizona's Fastest Internet to the City of Phoenix
-
Digital Infrastructure World 2027 Announces First 85 Speakers as Registrants Represent 80GW of AI Buying Capacity
-
Bill Shelow, LIBRA Insurance Partners President and CEO, Receives NAILBA’s 2026 Douglas Mooers Award for Excellence
-
Oleria Extends Identity Governance to AI Agents, Tracing Every Agent Through the People and Credentials It Acts For
The Untold Truth About President Trump's Marijuana Rescheduling
The untold truth? Rescheduling may not save the cannabis industry-it could divide it.
Past IRS 280E tax liabilities won't vanish-some companies owe hundreds of millions.
Interstate cannabis operators still remain barred from DEA licensing, regardless of tax changes.
Marijuana is still DEA regulated under the Controlled Substance Act and
WASHINGTON, DC / ACCESS Newswire / August 15, 2025 / President Donald Trump has signaled he is open to reclassifying marijuana under federal law, particularly for medical purposes, calling it a "very complicated subject" but acknowledging he's heard "good things" for pain and chronic disease.

If his administration follows through - especially with a move to separate recreational marijuana from FDA-regulated medical cannabis - it could trigger a seismic shift in the industry. For most cannabis companies, that shift may mean new compliance hurdles. But for MMJ International Holdings, it could open the fast lane to final DEA registration and the start of long-delayed clinical trials.
Why MMJ BioPharma Stands Apart
1. The "Medical Only" Fit
President Trump's comments reflect caution toward recreational use but an openness to true medical applications. MMJ 's entire business model is built for that environment:
FDA Orphan Drug Designations for Huntington's disease and Multiple Sclerosis.
Two active Investigational New Drug (IND) applications with the FDA.
A fully pharmaceutical pathway - no dispensaries, no state-level gray markets, no recreational overlap.
2. DEA Policy Advantage
Under current DEA policy, any applicant with ties to illegal state-to-state marijuana commerce will never receive a federal manufacturing registration. This policy instantly eliminates a large share of today's cannabis operators from the race if Trump orders stricter enforcement in parallel with rescheduling.
MMJ's record is clean - it has never engaged in state-licensed or illicit marijuana trade. That means it qualifies for DEA registration without the baggage that could block other companies.
3. Breaking the DEA Bottleneck
MMJ has waited more than seven years for DEA approval to cultivate cannabis for FDA clinical trials. With no Administrative Law Judge system currently functioning, and Terry Cole newly confirmed as DEA Administrator, a Trump directed policy change could result in immediate action on long-delayed, compliant applications like MMJ's.
4. MMJ Market Positioning
Most cannabis companies operate in a state-law gray zone, which leaves them exposed to enforcement and disqualifies them from federal registrations. MMJ's federally compliant approach means:
Legal protection under federal law once approved.
Eligibility for insurance reimbursement, national prescription networks, and pharmaceutical distribution channels.
5. First-Mover Timeline
MMJ is uniquely prepared to act fast:
Orphan Drug Designations in place.
INDs cleared with the FDA.
GMP-compliant manufacturing plans ready to execute.
If rescheduling happens and the DEA issues its registration, MMJ could plant its first federally approved cannabis crop within weeks - launching clinical trials far ahead of competitors.
Impact on the Broader Industry
Rescheduling to Schedule III would also have major tax implications by eliminating IRS Code 280E restrictions going forward. That means cannabis companies could deduct normal business expenses. But here's the catch:
Past 280E liabilities - in some cases amounting to hundreds of millions - won't automatically disappear.
The IRS may allow relief for the full year of the change, but retroactive forgiveness is unlikely without congressional action.
Companies engaged in illegal interstate commerce remain ineligible for DEA licensing regardless of tax changes.
In short, while rescheduling could provide tax breathing room for some, those outside the bounds of federal law will remain shut out of the legitimate pharmaceutical market.
Bottom Line
If President Trump follows through with rescheduling and reinforces the DEA's strict eligibility rules, MMJ BioPharma could become the flagship example of how cannabis can be developed as real medicine - safe, consistent, federally compliant, and backed by clinical science.
Where others will face disqualification, tax debt, or regulatory overhaul, MMJ will be ready to deliver exactly what Trump has said he's open to: medical cannabis for pain and chronic disease, regulated like any other prescription drug.
MMJ is represented by attorney Megan Sheehan.
CONTACT:
Madison Hisey
[email protected]
203-231-8583
SOURCE: MMJ International Holdings
View the original press release on ACCESS Newswire
A.O.Scott--AT